Source comparison
CJC-1295 No DAC vs Mod GRF + Ipamorelin — Key Differences
The peptide research community debates whether CJC-1295 No DAC paired with ipamorelin outperforms Mod GRF (modified GRF 1-29) blended with ipamorelin. But the premise contains a fundamental misconception. CJC-1295 No DAC and Mod GRF 1-29 are not competing comp
This comparison does not assign a generated winner or score.
- The peptide research community debates whether CJC-1295 No DAC paired with ipamorelin outperforms Mod GRF (modified GRF 1-29) blended with ipamorelin. But the premise contains a fundamental misconception. CJC-1295 No DAC and Mod GRF 1-29 are not competing compounds. They're the same peptide under two different commercial names, both referring to the 29-amino-acid sequence that acts as a growth hormone-releasing hormone (GHRH) analog. The confusion stems from early supplier mislabeling when DAC-bound (Drug Affinity Complex) CJC-1295. A distinct, longer-acting variant. Was first marketed. When researchers wanted the shorter-acting version without the DAC modification, suppliers began calling it 'CJC-1295 No DAC' to distinguish it from the original. Mod GRF 1-29 is the technically accurate term for this peptide.
- Our team has reviewed formulation data across hundreds of supplier batches in this space. The confusion isn't semantic. It creates real protocol errors. Researchers treating these as separate compounds often duplicate GHRH signaling unnecessarily or misinterpret dosing guidance written for one naming convention when using the other.
- Is CJC-1295 No DAC & ipamorelin better than Mod GRF + ipamorelin blend?
- No. Because CJC-1295 No DAC and Mod GRF 1-29 are identical peptides with the same amino acid sequence, mechanism, and half-life (approximately 30 minutes). The naming difference reflects supplier marketing, not molecular structure. Performance of either compound paired with ipamorelin depends on dosing protocol, injection timing relative to GH pulse windows, and individual hypothalamic-pituitary response. Not which label appears on the vial.
- What matters isn't the name on the bottle. It's understanding that both labels describe a GHRH analog with a 30-minute half-life, requiring precise timing around natural GH pulse windows (typically pre-sleep and post-exercise) to maximize efficacy when combined with ipamorelin, a growth hormone secretagogue (GHS) that amplifies the release signal. The rest of this article covers exactly how these peptides interact mechanistically, why the DAC vs No DAC distinction genuinely matters, and what dosing errors most protocols get wrong.